Tempus Shares Plummet 3.52% Amid 31.15% Surge in $680M Volume Ranked 152nd in Market Activity

On September 10, 2025, , marking a significant drop in investor sentiment. , , ranking it 152th in market activity. This surge in volume suggests heightened interest despite the downward price movement.

The decline in Tempus AI's share price may be attributed to broader market dynamics and sector-specific pressures. Analysts noted that the technology and AI-driven healthcare sectors faced mixed momentum, with investors reassessing growth projections amid macroeconomic uncertainties. However, the elevated trading volume indicates lingering market engagement, potentially signaling short-term volatility rather than a sustained bearish trend.

Key factors influencing Tempus' performance included evolving regulatory scrutiny in AI healthcare applications and competitive positioning within the biotech space. While the company has previously demonstrated resilience in high-volume trading environments, the recent dip underscores the sensitivity of its valuation to external macroeconomic factors and sector-wide sentiment shifts.

The following data-collection and back-testing workflow will be executed: The strategy scans the U.S. , 2022. It ranks stocks by dollar trading volume, , and enters equal-weighted long positions for a one-day holding period. , , volatility, , , . The back-test will cover the period from January 3, 2022, to September 10, 2025.